Fundraising Fox
/Companies
Sign in

Valanbio Therapeutics

Raleigh, US · Founded 2015 · Delaware corporation · 1 known investors

Find your way into Valanbio Therapeutics

Biotech

Founders & leadership

CD
Clayton DuncanNamed on SEC filing
PZ
Pei ZhouNamed on SEC filing
MAMoise A. Khayrallah
Moise A. KhayrallahChairman, Board of DirectorsCEO at Emergo Therapeutics
EJ
Eric J. TooneNamed on SEC filing
SH
Sam HopkinsNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$421K disclosed across 1 of 2 rounds · 2018–2020

▶$421KraisedJan 2020 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Clayton DuncanExecutive Officer, Director
  • Pei ZhouExecutive Officer, Director
  • Moise A. KhayrallahExecutive Officer, Director
  • Eric J. TooneDirector
  • Sam HopkinsDirector
Offering amount
$600K
Amount sold
$421K
Minimum investment
$7K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Valanbio Therapeutics's investors?
Valanbio Therapeutics's investors include Breakthrough Energy Ventures.
How much funding has Valanbio Therapeutics raised?
Valanbio Therapeutics has disclosed $421K raised across 1 of its 2 known rounds.
Where is Valanbio Therapeutics headquartered?
Valanbio Therapeutics is headquartered in Raleigh, US.